Neurofibromin 1 Impairs Natural Killer T-Cell-Dependent Antitumor Immunity against a T-Cell Lymphoma.

Liu, Jianyun; Gallo, Richard M; Khan, Masood A; Renukaradhya, Gourapura J; Brutkiewicz, Randy R

Liu, Jianyun; Gallo, Richard M; Khan, Masood A; Renukaradhya, Gourapura J; Brutkiewicz, Randy R.

Afiliación

Liu J; Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, United States.
Gallo RM; Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, United States.
Khan MA; Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, United States.
Renukaradhya GJ; College of Applied Medical Sciences, Al-Qassim University, Buraidah, Saudi Arabia.
Brutkiewicz RR; Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, United States.

Front Immunol ; 8: 1901, 2017.

Article en En | MEDLINE | ID: mdl-29354122

Palabras clave

CD1d; T-cell lymphoma; antitumor immunity; natural killer T cells; neurofibromin 1

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Immunol Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google